{"slideshow_credits": null, "snippet": "Marc Tessier-Lavigne, who will leave Rockefeller University to lead Stanford University, has also worked as an executive in the biotech industry,", "abstract": "Interview with incoming Stanford University president Marc Tessier-Lavigne reveals that his position on board of biotech company Juno Therapeutics will be reviewed to make sure no conflicts of interest exist.", "section_name": "U.S.", "print_page": "15", "document_type": "article", "byline": {"person": [{"firstname": "Stephanie", "role": "reported", "lastname": "SAUL", "rank": 1, "organization": ""}], "original": "By STEPHANIE SAUL", "contributor": "Andrew Pollack contributed reporting."}, "web_url": "http://www.nytimes.com/2016/02/06/us/marc-tessier-lavigne-new-stanford-president.html", "lead_paragraph": "Marc Tessier-Lavigne, who will leave Rockefeller University to lead Stanford University, has also worked as an executive in the biotech industry,", "headline": {"main": "New Stanford President Has Biotech Connection ", "print_headline": "New Stanford President Has Biotech Connection "}, "_id": "56b5547a38f0d86b498f99da", "word_count": "730", "multimedia": [], "pub_date": "2016-02-06T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"name": "persons", "value": "Tessier-Lavigne, Marc", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Colleges and Universities", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Juno Therapeutics Inc", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Rockefeller University", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Appointments and Executive Changes", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Biotechnology and Bioengineering", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "Stanford University", "is_major": "Y", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}